Edition:
United States

People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

16.81USD
23 Feb 2017
Change (% chg)

$-0.06 (-0.36%)
Prev Close
$16.87
Open
$16.83
Day's High
$16.95
Day's Low
$16.55
Volume
1,451,512
Avg. Vol
1,328,508
52-wk High
$17.49
52-wk Low
$8.18

McCourt, Thomas 

Mr. Thomas A. McCourt is Senior Vice President - Marketing and Sales, Chief Commercial Officer of Ironwood Pharmaceuticals, Inc., since September 2009. Mr. McCourt led the U.S. brand team for denosumab at Amgen Inc. from April 2008 to August 2009. Prior to that, Mr. McCourt was with Novartis AG from 2001 to 2008, where he directed the launch and growth of Zelnorm for the treatment of patients with IBS-C and CIC and held a number of senior commercial roles, including vice president of strategic marketing and operations. Mr. McCourt was also part of the founding team at Astra Merck Inc., leading the development of the medical affairs and science liaison group and then serving as brand manager for Prilosec™ and NEXIUM®. Mr. McCourt has a degree in pharmacy from the University of Wisconsin.

Basic Compensation

Total Annual Compensation, USD 663,600
Restricted Stock Awards, USD 253,825
Long-Term Incentive Plans, USD --
All Other, USD 700,733
Fiscal Year Total, USD 1,618,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 40,000 468,000.00
Name Fiscal Year Total

Terrance McGuire

239,850

Peter Hecht

4,124,990

Thomas Graney

1,096,390

Mark Currie

2,424,720

Thomas McCourt

1,618,160

Halley Gilbert

1,550,880
As Of  30 Dec 2015